Companies: 10,740     total market cap: ยฃ100.161 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณ$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Sarepta Therapeutics
SRPT
#4272
Rank
ยฃ1.86 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
ยฃ17.79
Share price
34.98%
Change (1 day)
-68.71%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Revenue for Sarepta Therapeutics (SRPT)

Revenue in 2024: ยฃ1.51 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ1.80 Billion. In 2024 the company made a revenue of ยฃ1.51 Billion an increase over the revenue in the year 2023 that were of ยฃ0.97 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sarepta Therapeutics from 1997 to 2024

Annual revenue

Year Revenue Change
2024ยฃ1.51 B55.3%
2023ยฃ0.97 B26.54%
2022ยฃ0.77 B48.32%
2021ยฃ0.51 B31.23%
2020ยฃ0.39 B36.43%
2019ยฃ0.29 B22.46%
2018ยฃ0.23 B107.34%
2017ยฃ0.11 B2503.45%
2016ยฃ4.39 M419.6%
2015ยฃ0.84 M-86.51%
2014ยฃ6.26 M-27.3%
2013ยฃ8.62 M-62.68%
2012ยฃ23.09 M-23.61%
2011ยฃ30.23 M58.63%
2010ยฃ19.05 M75.34%
2009ยฃ10.86 M-25.06%
2008ยฃ14.5 M162.31%
2007ยฃ5.52 M9294.6%
2006ยฃ0.05 M-97.88%
2005ยฃ2.77 M1137.2%
2004ยฃ0.22 M-58.64%
2003ยฃ0.54 M3.89%
2002ยฃ0.52 M7.16%
2001ยฃ0.48 M-43.97%
2000ยฃ0.86 M602.26%
1999ยฃ0.12 M-48.55%
1998ยฃ0.24 M31.72%
1997ยฃ0.18 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Gilead Sciences
GILD
ยฃ22.03 B 1,119.74%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
ยฃ1.29 B-28.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.76 B-57.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ2.78 B 53.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
ยฃ0.45 B-74.88%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.65 B-63.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
ยฃ14.04 M-99.22%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com